End of an era at Apple, the GLP-1 surprise & top holdings of global fund managers

Equity Mates Investing Podcast31mApril 22, 2026

Get the full intelligence

Search transcripts, export clips, track mentions, and explore all topics from “End of an era at Apple, the GLP-1 surprise & top holdings of global fund managers” inside PodZeus.

AI-Generated Summary

This episode of the Equity Mates Investing Podcast dives into several major financial stories, beginning with the surprising health benefits of GLP-1 drugs beyond weight loss—highlighting a compelling anecdote of a woman recovering from severe concussion using Zep Bound. The discussion then shifts to Apple’s leadership transition, as Tim Cook steps down after a 15-year tenure that transformed Apple into a $4 trillion company. Hosts Bryce and Ren debate Apple’s AI strategy, with Ren arguing that Apple’s strength lies in distribution rather than building large language models, while Bryce remains cautious about future innovation. The episode celebrates Brad Jacobs, founder of QXO, as a serial billionaire entrepreneur who’s once again consolidating the building materials industry through a high-velocity roll-up strategy. In the investing segment, the hosts answer listener questions on portfolio construction, leverage, and debt recycling, emphasizing disciplined processes and transparency. Finally, a deep dive into the top 13 Australian global equity fund managers reveals strong concentration in mega-cap tech—Amazon, Microsoft, and Meta—alongside key non-Magnificent Seven names like Visa and TSMC, underscoring the importance of analyzing active manager differentiation beyond headline holdings.

Key Takeaways
1

GLP-1 drugs like Zep Bound may offer unexpected benefits beyond weight loss, including recovery from severe concussion, based on compelling anecdotal evidence.

2

Tim Cook’s 15-year Apple leadership delivered 2,000% returns and transformed Apple into the first $4 trillion company, but future growth hinges on AI integration without product innovation.

3

Brad Jacobs is building QXO into a dominant North American building products distributor through a repeatable roll-up strategy, backed by his proven track record of founding eight billion-dollar companies.

4

Top global fund managers show strong overlap in mega-cap tech (Amazon, Microsoft, Meta), but significant divergence in other holdings—highlighting the need to assess active manager differentiation.

5

Debt recycling strategies vary: some use ongoing income recycling, while others, like the hosts, use a one-time leverage shift to convert non-deductible debt into tax-deductible investment debt.

…and 2 more takeaways available in PodZeus

Chapters
0:00
2 min

Introduction & Sponsorship

The episode opens with standard disclaimers and sponsor segments for Viola Private Wealth and Vanta, setting the stage for a high-impact discussion on Apple, GLP-1 drugs, and top fund manager holdings.

2:20
3 min

The GLP-1 Surprise: Beyond Weight Loss

She scored 100 out of 132, extreme impairment. She got that score eight years later in February 2025. Spoke to some researchers who were looking at concussion. They suggested speak to your doctor about an off-label use of GLP-1 drugs. She started using Zetbound, and within weeks she went from 100 out of 132 to 6 out of 132.

Highlight
5:00
5 min

Tim Cook Steps Down: Legacy & Future

I don't think they've missed the boat. They're not going down the we're going to build an LLM. So all they can do is integrate.

Highlight
10:00
5 min

Brad Jacobs: The Billion-Dollar Roll-Up King

He's done it before. Looks like he's absolutely going to be doing it again. It's an amazing story.

Highlight
15:00
5 min

Portfolio Strategy & Listener Q&A

Hosts address listener questions on leverage, debt recycling, and portfolio construction, with Bryce emphasizing a formalized thesis process and Ren clarifying his one-time debt recycling approach.

High-Impact Quotes
She scored 100 out of 132, extreme impairment. She got that score eight years later in February 2025. Spoke to some researchers who were looking at concussion. They suggested speak to your doctor about an off-label use of GLP-1 drugs. She started using Zetbound, and within weeks she went from 100 out of 132 to 6 out of 132.
Ren6:01
Viral: 90.0
He's done it before. Looks like he's absolutely going to be doing it again. It's an amazing story.
Bryce14:54
Viral: 85.0
Even with high overlap in top holdings, active managers can deliver vastly different results—ranging from +34.5% (Orbis) to -19.3% (GCQ)—emphasizing the importance of long-term evaluation over short-term performance chasing.
Ren53:00
Viral: 82.0
Speakers

Hosts

BryceRen
Topics Discussed
GLP-1 Drug Therapeutics95%Apple Leadership Transition90%Billion-Dollar Entrepreneurship88%Active Fund Manager Analysis87%Roll-Up Business Strategy85%Global Equity Portfolio Construction80%Debt Recycling & Borrowing to Invest75%AI Integration in Consumer Tech70%
People & Brands

Apple

organization

24xPositive

Bryce

person

20xNeutral

GLP-1

other

18xPositive

Ren

person

18xNeutral

Brad Jacobs

person

14xPositive

QXO

organization

12xPositive

Tim Cook

person

12xPositive

Amazon

organization

10xPositive

Microsoft

organization

9xPositive

Meta

organization

6xPositive

Get the full intelligence

Search transcripts, export clips, track mentions, and explore all topics from “End of an era at Apple, the GLP-1 surprise & top holdings of global fund managers” inside PodZeus.

Start discovering podcast insights today

Start with a 7-day trial and explore a growing catalog of popular podcasts. No credit card required.

No credit card required • 7-day trial • Cancel anytime